iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

Rhea-AI Summary

Insight Molecular Diagnostics (Nasdaq: IMDX) will release its second quarter 2026 financial results after the market close on Monday, August 10, 2026. Management will host a live Zoom webinar at 2:00 pm PT / 5:00 pm ET, with Q&A and an archived replay available on the company’s investor website.

On August 11, 2026, CEO Josh Riggs and CFO Andrea James will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, holding virtual one-on-one meetings with registered investors who schedule via their Needham sales representative.

Market Context

The prior earnings-date record showed mixed responses: 2026-05-06 was -1.39% and 2026-03-20 was +8.6...

Analysis

The prior earnings-date record showed mixed responses: 2026-05-06 was -1.39% and 2026-03-20 was +8.67%. This scheduling notice adds timing only; low short positioning provides limited squeeze-related context, while the Q2 release remains the key watchpoint.

Key Figures

Reporting Period: Q2 2026 Results Release Date: August 10, 2026 Webinar Time: 2:00 pm PT / 5:00 pm ET +3 more

6 metrics

Reporting Period Q2 2026 Financial results

Results Release Date August 10, 2026 After market close

Webinar Time 2:00 pm PT / 5:00 pm ET Q2 2026 results discussion

Conference Edition 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Conference Dates August 10-11, 2026 Needham Virtual MedTech & Diagnostics 1x1 Conference

Investor Meetings Date August 11, 2026 Virtual one-on-one meetings

Previous Earnings date Reports

2 past events · Latest: May 06 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
May 06	Q1 earnings date	Neutral	-1.4%	Scheduled Q1 results; shares declined 1.39% over 24 hours.
Mar 20	Q4 earnings date	Neutral	+8.7%	Scheduled Q4 results and Needham conference; shares rose 8.67% over 24 hours.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-specific earnings-date announcements produced mixed 24-hour reactions, ranging from -1.39% to +8.67%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NASHVILLE, Tenn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026. iMDx will host a live Zoom webinar to discuss the company's financial results at 2:00 pm PT / 5:00 pm ET that same day.

The live webinar to discuss financial results, followed by Q&A, will be accessible via registration at the following link: iMDx Q2 2026 Earnings Webinar.

An archived replay will be available after the call concludes on iMDx’s website within the Investors/Events & Presentations section.

Attendance at 11th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference

Separately, on August 11th, Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, being held August 10-11, 2026.

iMDx management will be conducting virtual one-on-one meetings on August 11^th with investors registered for the conference. Investors wishing to book a meeting are encouraged to reach out to their Needham sales representative.

About Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information.

GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.

Investor Contact:
Douglas Farrell
LifeSci Advisors LLC
imdx@lifesciadvisors.com 

FAQ

When will iMDx (Nasdaq: IMDX) report its Q2 2026 earnings results?

iMDx will report its Q2 2026 financial results after the market closes on Monday, August 10, 2026. According to iMDx, the release will be followed by a same-day Zoom webinar for investors.

What time is the iMDx (IMDX) Q2 2026 earnings webinar on August 10, 2026?

The iMDx Q2 2026 earnings webinar is scheduled for 2:00 pm PT / 5:00 pm ET on August 10, 2026. According to iMDx, the live Zoom event will include a discussion of results and Q&A.

How can investors access the iMDx Q2 2026 earnings call and replay (IMDX)?

Investors can access the live Q2 2026 earnings webinar via a registration link titled “iMDx Q2 2026 Earnings Webinar”. According to iMDx, an archived replay will be posted in the Investors/Events & Presentations section of its website.

Will there be Q&A during the iMDx (IMDX) Q2 2026 earnings webinar?

Yes, the iMDx Q2 2026 earnings webinar will include a discussion of financial results followed by a Q&A session. According to iMDx, the event is hosted live on Zoom with investor participation via registration.

Is iMDx (IMDX) attending the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference?

Yes, iMDx will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026. According to iMDx, CEO Josh Riggs and CFO Andrea James will hold virtual one-on-one investor meetings.

How can investors schedule one-on-one meetings with iMDx at the Needham MedTech & Diagnostics 1x1 Conference?

Investors can request one-on-one meetings with iMDx management for August 11, 2026, through their Needham sales representative. According to iMDx, these virtual meetings occur during the Needham Virtual MedTech & Diagnostics 1x1 Conference.